5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | NEUTRAL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.82▲ | 2.80▲ | 2.80▲ | 2.81▼ | 3.01▼ |
MA10 | 2.80▲ | 2.82▲ | 2.81▲ | 2.81▲ | 2.62▲ |
MA20 | 2.81▲ | 2.82▲ | 2.83▼ | 3.00▼ | 2.15▲ |
MA50 | 2.83▼ | 2.81▲ | 2.79▲ | 2.48▲ | 2.54▲ |
MA100 | 2.79▲ | 2.84▼ | 2.93▼ | 2.13▲ | 4.89▼ |
MA200 | 2.83▼ | 3.07▼ | 3.08▼ | 2.33▲ | 9.50▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | -0.003▼ | -0.002▼ | -0.067▼ | 0.174▲ |
RSI | 51.309▲ | 50.270▲ | 50.450▲ | 49.495▼ | 55.965▲ |
STOCH | 86.566▲ | 41.865 | 43.452 | 39.571 | 37.371 |
WILL %R | -16.667▲ | -37.500 | -37.500 | -63.566 | -66.536 |
CCI | 43.130 | -17.284 | 12.635 | -43.457 | 33.595 |
Thursday, September 04, 2025 07:04 AM
Soligenix, Inc. (NASDAQ: SNGX) shares slumped sharply Thursday. The Princeton, New Jersey-based Soligenix, a late-stage biopharmaceutical company focused on developing and commercializing products to ...
|
Thursday, September 04, 2025 04:50 AM
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
|
Monday, August 18, 2025 04:54 AM
(RTTNews) - Soligenix (SNGX) announced that the Office of Orphan Products Development of FDA has granted orphan drug designation to dusquetide, the active ingredient in SGX945, for treatment of Behçet ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 2.79 | 2.84 | 2.78 | 2.81 | 59,473 |
16/09/25 | 2.82 | 2.86 | 2.77 | 2.79 | 129,996 |
15/09/25 | 2.86 | 2.9194 | 2.75 | 2.75 | 184,386 |
12/09/25 | 2.795 | 2.98 | 2.74 | 2.92 | 218,403 |
11/09/25 | 2.78 | 2.90 | 2.73 | 2.78 | 136,531 |
10/09/25 | 2.72 | 2.8199 | 2.69 | 2.78 | 149,246 |
09/09/25 | 2.59 | 2.78 | 2.575 | 2.68 | 193,329 |
08/09/25 | 2.82 | 2.8542 | 2.65 | 2.66 | 359,966 |
05/09/25 | 3.07 | 3.07 | 2.86 | 2.86 | 234,583 |
04/09/25 | 2.90 | 3.11 | 2.72 | 3.04 | 4,947,649 |
|
|
||||
|
|
||||
|
|